Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discount will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Business
Agilent Technologies has signed a deal to buy ACEA Biosciences for $250 million. The privately held cell analysis instrument maker, founded in 2002, will expand Agilent’s portfolio of tools for life sciences research and clinical diagnostics. Agilent calls cell analysis a strategic growth area that it entered in 2015 with the $235 million acquisition of Seahorse Bioscience. Earlier this year, the firm bought Ireland-based Luxcel Biosciences, a maker of biosensors and assays for analyzing cell metabolism.
This article has been sent to the following recipient: